A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
Marc ZumbergJed B GorlinElizabeth A GriffithsGarry SchwartzBradley S FletcherKatherine WalshKim-Hien DaoAmanda VansandtMauricio LynnAryeh ShanderPublished in: Transfusion (2020)
Administration of HBOC-201 over an extended period is a feasible and safe oxygen bridge for severely anemic patients who cannot be transfused with RBC.